Description
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment.
This report explains events in the market and provides lists of companion products. It also provides market sizing and forecasts models for companies engaged in the market or those who are assessing its potential.
This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information, with forecasts to 2018
Infectious Disease
Neurological Disorders
Oncology
Blood
Metabolic
Cardiovascular
The situation with compainion diagnotics is fluid. Uptake was because companion tests lacked FDA approval, which prevented promotion But the realization that companion diagnostics can cut costs will most likely benefit from a therapy and ruling out those therapies has ensured a pathway.
There are many competitors in the market which include large multiproduct companies such as Siemens, Roche and Beckman Coulter and small niche developers such as Diagenic 20/20 GeneSystems.
Companies profiles in this report include:
- 20/20 GeneSystems
- Abbott Laboratories
- Affymetrix
- Agendia
- Alere
- Beckman Coulter
- Becton Dickinson
- Biocartis SA
- Biodesix
- bioMerieux
- BioReference Laboratory
- bioTheranostics
- CardioDX
- Celera Alameda
- Clarient
- deCODE Genetics
- DiaGenic
- Genomic Health
- Genoptix Medical Laboratory
- Illumina
- Johnson & Johnson
- Life Techologies
- Memory Dx
- Myriad Genetics
- Nanostring Technologies
- OPKO Health
- Provista Dx
- Qiagen
- Roche
- Seimens Healthcare
- Singulex
- Thermo Fisher Scientific
The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from secondary sources and interviews with experts. including research scientists, business development managers and marketing managers.microbiologists, pathologists, hospital authorities and reimbursement specialists.
Table of Contents
ONE: EXECUTIVE SUMMARY
Overview
Scope and Methodology
Total Size and Growth of the Market
Issues and Trends Affecting Market
Leading Competitors
TWO: INTRODUCTION TO THE COMPANION DIAGNOSTICS INDUSTRY
Overview
Biomarkers
Types of Biomarkers
Biomarkers as Treatment Selection Tool
Biomarkers as Therapy Monitoring Tool
Personalized Medicine
Potential Benefits
Privacy and Public Perception
THREE: INDUSTRY TRENDS
The Health Industry
Population Demographics
Life Expectancy
Chronic Disease Impact
Disease and An Aging Population
Healthcare Reform in the United States
Co-Development and Partnership Deals
Companion Diagnostic Business Model
Reimbursement Issues
Antimicrobial Drug Resistance
BRIC Involvement
Regulatory Structure
Molecular Test Reimbursement
FOUR: COMPANION DIAGNOSTIC PRODUCTS
Cancer
Overview
Biochemistry of Cancer Cells
Carcinogen Metabolism
Causes of Cancer Growth
Environmental Factors, DNA, RNA
Cellular Oncogenes
Tumor Suppressor Genes
History of Cancer
Cancer Types
Cancer Biomarker Examples
New Developments
Cancer Companion Diagnostics
Selected Cancer Companion Diagnostics in Development
Cardiovascular
Overview
The Cardiovascular System
Heart
Circulatory System
Cardiac Cycle
Coronary Circulation
Cardiac Myocytes
Molecular Contraction
Cardiovascular and Blood Diseases
Ischemic Heart Disease
Chronic Ischemic Cardiomyopathy
Sudden Cardiac Death
Valvular and Endocardial Diseases
Mitral Valve Disorders
Aortic Valve Disorders
Rheumatic Heart Disease
Endocarditis
Pericardial Diseases
Pericardial Effusion
Pericarditis
Myocardial Diseases
Myocarditis
Cardiomyopathy
Congenital Heart Diseases
Atrial Septal Defect
Ventral Septal Defect
Pulmonary Stenosis
Aortic Stenosis
Coarctation of the Aorta
Patent Ductus Arteriosus
Truncus Arteriosus
Transposition of the Great Arteries
Tricuspid Atresia
Congestive Heart Failure
Etiology
Cardiac Dysrhythmias
Hypertension
Risk Factors
Effects of High Blood Pressure
Blood Disorders
Hyperlipidemia
Biomarker Availability
New Developments
Companion Diagnostics
Selected Cardiovascular Companion Diagnostics in Development
Endocrine, Autoimmune
Overview
The Endocrine System
Hormone Function
Hormone Synthesis
Immune System
Autoimmunity
Genetic Factors
Environmental Factors
Inflammatory Disorders
Disease Overview
Classification of Endocrine Disorders
Growth Hormone Disorders
1Etiology of Growth Hormone
Antidiuretic Hormone Disorders
Etiology
Thyroid Hormone Disorders
Hypothyroidism
Hyperthyroidism
Adrenocortical Hormone Disorders
Diabetes Mellitus
Type 1 Diabetes
Type 2 Diabetes
Rheumatic Arthritis
Biomarker Availability
New Developments
Companion Diagnostics
Infectious Disease
Overview
Infection
Infectious Diseases
HIV Disease
Hepatitis C
Human Papillomavirus (HPV)
Sepsis
Biomarker Availability
New Developments
Companion Diagnostics
Central Nervous System
Overview
The Nervous System
Central Nervous System
Peripheral Nervous System
Autonomic Nervous System
Nervous System Disorders
Alzheimer’s Disease
Multiple Sclerosis
Parkinson’s Disease
Stroke
Biomarker Examples
New Developments
Companion Diagnostics
FIVE: MARKET SIZE AND GROWTH
Market Considerations
Market Overview
Companion Diagnostics Market by Geographical Region
SIX: COMPANY PROFILES
Introduction
20/20 GeneSystems, Inc.
Company Overview
Abbott Laboratories
Company Overview
Affymetrix
Company Overview
Agendia, Inc. USA
Company Overview
Alere, Inc
Company Overview
Asuragen, Inc.
Company Overview
Beckman Coulter, Inc
Company Overview
Becton, Dickinson
Company Overview
Biocartis S.A.
Company Overview
Biodesix, Inc.
Company Overview
bioMerieux SA
Company Overview
BioReference Laboratories, Inc
Company Overview
bioTheranostics, Inc.
Company Overview
CARDIODX, INC
Company Overview
CELERA ALAMEDA
Company Overview
Clarient, Inc
Company Overview
deCODE Genetics, Inc.
Company Overview
DiaGenic ASA
Company Overview
Genomic Health, Inc.
Company Overview
Genoptix Medical Laboratory
Company Overview
Illumina, Inc.
Company Overview
Johnson & Johnson
Company Overview
Life Technologies Corporation (part of Thermo Fisher)
Company Overview
Memory Dx
Company Overview
Myriad Genetics, Inc.
Company Overview
Nanostring Technologies, Inc.
Company Overview
OPKO Health, Inc.
Company Overview
Provista Dx
Company Overview
Qiagen N.V.
Company Overview
Roche
Company Overview
SIEMENS HEALTHCARE
Company Overview
Singulex, Inc
Company Overview
Thermo Fisher Scientific
Company Overview
APPENDIX: LIST OF CONTRIBUTORS
